Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT1/3C.

Transplantation - 15 Jul 2003

Tassaneeyakul Wichittra, Srimarthpirom Somrudee, Reungjui Sirirat, Chansung Kanchana, Romphruk Amornrat, Tassaneeyakul Wongwiwat

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azathioprine
Share to Fatal Outcome
Share to Genetic Carrier Screening
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunosuppressive Agents

Share to Kidney Transplantation

Share to Methyltransferases

Share to Time Factors

Source

Identifiers

PMID: 12865824
DOI: 10.1097/01.TP.0000070521.22024.F1

Genes

TPMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C.PMID 12865824Read ↗

Severe azathioprine-induced myelotoxicity in a kidney transplant patient with thiopurine S-methyltransferase-deficient genotype (TPMT*3A/*3C).Semantic proximity Read ↗

Characterization of a novel TPMT mutation associated with azathioprine-induced myelosuppression.Semantic proximity Read ↗

Azathioprine-related myelosuppression in a patient homozygous for TPMT*3A.Semantic proximity Read ↗

Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism.Semantic proximity Read ↗

Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.Semantic proximity Read ↗

Rare gene variants in a patient with azathioprine-induced lethal myelosuppression.Semantic proximity Read ↗

Thiopurine S-methyltransferase genotype predicts azathioprine-induced myelotoxicity in kidney transplant recipients.Semantic proximity Read ↗

The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.Semantic proximity Read ↗

Heterozygosity for the thiopurine methyltransferase *3A allele in an acute non-lymphoblastic leukaemia patient with delayed marrow regeneration following H-DAT chemotherapy.Semantic proximity Read ↗

Thiopurine S-methyltransferase gene polymorphism is predictive of azathioprine-induced myelosuppression in heart transplant recipients.Semantic proximity Read ↗

Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.